Interestingly enough, in 6-OHDA rats, the dual GLP-1/GIP agonist (DA5-CH), in addition to promoting the survival of dopaminergic neurons, was able to reduce the levels of monomer and oligomers of -synuclein, thus providing a wider neuroprotective effect [53]
Change history 17 June 2026 In the version of this article initially published online, there were duplication errors in the Extended Data Fig
Cell 16 , 34253437 (2005)
In practice, the GLP-1 and GIP components counteract this effect
In the SUSTAIN FORTE clinical trials, participants in the semaglutide (Ozempic) group showed an average reduction of 2.2 percentage points in the HbA1c levels with a 2 mg weekly dosage and 1.9 percentage points with a 1 mg weekly dosage of semaglutide after 40 weeks
Since there are many factors to consider with any weight loss plan (blood sugar control, exercise, severe hypoglycemia, and insulin intake), speak with your healthcare provider about what daily calorie intake, nutrition plan and exercise routine are best for you